Categories News Press Releases Archives 2025 December November October September August July June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November September August June May March February January 2021 December November October September August May April February Dec 08 UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder Read More Share:| | | Dec 04 UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting Read More Share:| | | Dec 03 Bridging Strategy and Innovation: Leadership in Action through the AES BRIDGE Program Read More Share:| | |